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Abstract
Nanoparticle (NP) exposure has been closely associated with the exacerbation and pathophysiology of many respiratory
diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. Mucus hypersecretion and accumulation in
the airway are major clinical manifestations commonly found in these diseases. Among a broad spectrum of NPs, titanium
dioxide (TiO2), one of the PM10 components, is widely utilized in the nanoindustry for manufacturing and processing of
various commercial products. Although TiO2 NPs have been shown to induce cellular nanotoxicity and emphysema-like
symptoms, whether TiO2 NPs can directly induce mucus secretion from airway cells is currently unknown. Herein, we
showed that TiO2 NPs (,75 nm) can directly stimulate mucin secretion from human bronchial ChaGo-K1 epithelial cells via a
Ca
2+ signaling mediated pathway. The amount of mucin secreted was quantified with enzyme-linked lectin assay (ELLA).
The corresponding changes in cytosolic Ca
2+ concentration were monitored with Rhod-2, a fluorescent Ca
2+ dye. We found
that TiO2 NP-evoked mucin secretion was a function of increasing intracellular Ca
2+ concentration resulting from an
extracellular Ca
2+ influx via membrane Ca
2+ channels and cytosolic ER Ca
2+ release. The calcium-induced calcium release
(CICR) mechanism played a major role in further amplifying the intracellular Ca
2+ signal and in sustaining a cytosolic Ca
2+
increase. This study provides a potential mechanistic link between airborne NPs and the pathoetiology of pulmonary
diseases involving mucus hypersecretion.
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Introduction
Many published reports have demonstrated the association
between NP exposure and pulmonary morbidity and mortality
[1,2,3]. The adverse effects induced by NPs seem to exacerbate
clinical symptoms ofpre-existing respiratoryillnesses suchasasthma,
COPD and Cystic Fibrosis (CF) [1,2,3,4,5,6]. During NP exposure,
individuals with respiratory diseases showed more incidences of
bronchoconstriction, medication use, bronchial hyperreactivity and
lung fibrosis [2,7]. TiO2 NPs are widely used in the nanotechnology
industry due to their vast array of applications that range from
household commodities, such as components of paints and carpets,
to personal products that include cosmetics, textiles, sunscreens and
foods [8,9]. TiO2 is also one of the PM10 components commonly
found in industries or manufacturing plants involved in processing
mineral ore rutile [10]. It has been reported that .50% of TiO2 NP
exposed workers had respiratory symptoms accompanied by
reduction in pulmonary function [10,11]. Other reports have also
indicated that inhalation of TiO2 NPs can induce pulmonary
inflammatory responses (characterized by neutrophil recruitment),
epithelial cell death and increased permeability [2,9]. Furthermore,
TiO2 NPs have been shown to play a role in inducing epithelial
fibroproliferative changes, stimulating goblet cell hyperplasia and in
instigating emphysema-like (such as alveolar enlargement) damages
in the lungs [2,10,12]. Overall, nanotoxicity induced by TiO2 NP
exposure in both the occupational and ambient environment
presents a significant and realistic health concern.
The harmful effects of NPs on the respiratory system not only
encompass cellular apoptosis/necrosis, but also mucus hyperpro-
duction which is closely associated with the pathogenesis of
pulmonary diseases that include asthma, COPD and CF [2,10,13].
In these chronic pulmonary diseases, mucus hypersecretion and
accumulation may lead to recurrent episodes of chronic bacterial
infections, limited airflow and chronic inflammatory responses
[2,14,15]. However, whether TiO2 NPs can directly induce mucin
secretion has not been resolved.
Airway mucus plays a vital role in the constant clearance of
inhaled pathogens and particulates. Mucus is a large, highly
glycosylated protein consisting of an array of mucin peptides
(apomucin) [14]. With their oligosaccharide sidegroups, such as
sialic acid, sulfate, and carboxyl (COO
2), mucins are usually
polyanionic in nature [16]. Mucin secretion is closely regulated by
cytosolic Ca
2+ concentrations ([Ca
2+]C) in various epithelial cells
[17]. A rise in [Ca
2+]C is crucial for initiating a cascade of down
stream events including the mobilization of granule-bound Ca
2+,
docking of the secretory granules, fusion of the plasma-granule
membrane and the formation of secretory pores, therefore leading
to the exocytosis of the mucin granules [18].
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16198Agonist-induced opening of various Ca
2+ channels expressed on
the cell membrane allows the influx of extracellular Ca
2+, which
may serve as the external Ca
2+ source [19]. The initial upsurge in
the [Ca
2+]C is usually relayed by triggering a secondary wave of
Ca
2+ propagation from internal stores, such as the ER
[19,20,21,22]. Ryanodine receptors (RYRs) on the ER have
multiple allosteric Ca
2+ binding sites responsible for triggering
Ca
2+- induced Ca
2+ release (CICR) into the cytosol [19,20,21,22].
The resultant increase in [Ca
2+]C could activate other cytosolic
proteins and modulate secretion of mucin, hormones or various
neurotransmitters [17,23,24].
NPs have been shown to disturb cellular functions by elevating
intracellular Ca
2+ levels [25,26,27,28]. For example, ultrafine
carbon black NPs can elicit Ca
2+-dependent secretion through the
activation of L-type voltage-gated Ca
2+ channels [25,26,28].
However, little is known regarding the intricate calcium signaling
pathway regulating the exocytotic events of secretory products. In
this study, we aim to investigate the mechanism through which




1. Culture of ChaGo-K1 cells
The human airway bronchial epithelial cell line ChaGo-K1,
obtained from American Type Culture Collection (ATCC,
Manassas, VA, USA), was used because it expresses MUC
proteins and secretes mucin [29]. Cells were cultured in 15 cm
cell culture plates (VWR, CA, USA) in RPMI 1640 medium
(Invitrogen, CA, USA) supplemented with L-glutamine, 1%
penicillin/streptomycin and 10% heat inactivated fetal bovine
serum (FBS). Cultures were incubated in a humidified incubator at
37uC/5% CO2. Cell counts were performed using trypan blue
(Sigma-Aldrich, MO, USA) exclusion and a Bright-Line haemo-
cytometer.
2. Nanoparticles and characterization
A mixture of anatase and rutile forms of ultrafine titanium (IV)
dioxide (,75 nm) (Sigma-Aldrich, MO, USA) was used in this
study because this form has been shown to result in more severe
cellular injuries [30,31]. The TiO2 NPs have a surface area of
36 m
2/g and the dispersion conductivity is 1040 mS/cm (infor-
mation from Sigma). All NP samples were sonicated before usage.
The concentrations used were 1 mg/ml, 0.75 mg/ml, 0.5 mg/ml,
0.25 mg/ml, 0.1 mg/ml, and 0.05 mg/ml. The range of concen-
trations used was consistent with the concentrations of TiO2 NPs
found in previous reports [30]. The TiO2 NPs were reconstituted
with Hanks’ solution (Invitrogen, CA, USA) before being tested.
The size of NPs was independently confirmed using homodyne
dynamics laser scattering (DLS) as described in previous studies
[32,33].
3. Cell preparation
Cells were seeded at 2610
5 cells per well in a 24-well plate, and
incubated for 24 hrs in RPMI 1640 supplemented with 10% FBS.
Following 24 hr incubation, the RPMI medium was removed
from the cells and the culture was rinsed with Hanks’ solution
twice before use.
4. Measurements of cytosolic Ca
2+ concentrations
induced by TiO2 exposure
The cells were then loaded with a Rhod-2 AM dye (1 mM)
(Kd=570 nM, lEx=552 nm and lEm=581) (Invitrogen, CA,
USA) for 45 minutes. After the dye loading, the cells were rinsed,
incubated with either normal Hanks’ or Ca
2+-free Hanks’ solution,
and treated with the appropriate TiO2 concentrations. All calcium
signaling experiments were carried out on a thermoregulated stage
at 37uC mounted on a Nikon microscope (Nikon Eclipse TE2000-
U, Tokyo, Japan). ChaGo-K1 cells were incubated with cadmium
chloride (200 mM; Sigma-Aldrich, MO, USA) to block the
membrane Ca
2+ channels [34], followed by TiO2 NP stimulation.
To investigate the interaction between TiO2 and membrane Ca
2+
channels, nifedipine (10 mM; Sigma-Aldrich, MO, USA), an L-
type Ca
2+ channel blocker [27], was added to ChaGo-K1 cells
prior to the exposure of TiO2. Antioxidant N-acetylcysteine (NAC,
250 mM; Sigma-Aldrich, MO, USA) was also added to ChaGo-K1
cells to study the involvement of reactive oxygen species (ROS)
[27,35], possibly generated as a result of TiO2 stimulation, and the
activation of Ca
2+ channels. Thapsigargin (100 nM; Sigma-
Aldrich, MO, USA) [18] and ryanodine (100 mM; Sigma-Aldrich,
MO, USA) were added separately to deplete the ER Ca
2+ content
and to inhibit the CICR mechanism [20,21], correspondingly.
These two blockers were utilized to investigate the contribution
from the internal ER Ca
2+ pool.
5. Calcein dye leakage measurements
ChaGo-K1 cells were seeded at the density of 2610
5 cells per
well in a 24-well plate and cultured for 24 hrs. TiO2 NP prepared
with calcein fluorescent dye (50 mM) (Invitrogen, CA, USA) in
Hanks’ solution was incubated with the cells for 5 minutes at 37uC.
Calcein is a biological inert green-fluorescent molecule of a
molecular mass of 623 Da and an estimated molecular radius of
0.6 nm [36]. TiO2 NP solution containing the calcein dye was
then removed and cells were rinsed twice with PBS to remove
possible remnants of calcein dye in the extracellular solution. The
cells were subsequently stained with a fluorescent nucleus dye,
hoechst (10 mM) (Sigma-Aldrich, MO, USA), for 5 mintues at
37uC and thoroughly rinsed again [33]. Fresh Hanks’ solution was
added into each well before taking fluorescent images of calcein
and hoechst loaded cells with a Nikon fluorescence microscope. A
percentage of calcein loaded cells against total number of cells, as
indicated by hoechst fluorescence, was calculated for each of the
TiO2 NP concentrations used in the experiment.
6. Mucin secretion and ELLA Preparation
The cells were seeded at 2610
5 cells per well in a 24-well plate
and cultured for 24 hrs. ChaGo-K1 cells were then rinsed with
PBS and treated with BAPTA-AM (Invitrogen, CA, USA),
thapsigargin (Sigma-Aldrich, MO, USA) or ryanodine (Sigma-
Aldrich, MO, USA) for at least 30 minutes. Afterward the cells
were stimulated for 15 minutes with the corresponding TiO2 NP
concentrations (0.75 mg/ml, 0.5 mg/ml, 0.25 mg/ml, and
0.1 mg/ml) or ionomycin (1 mM) (positive control) (Sigma-Aldrich,
MO, USA), both prepared in PBS. The supernatant containing
secreted mucin was collected and briefly centrifuged at 8,000 rpm
to remove the residual TiO2 NPs. The supernatant was then
incubated in a 96 well (Nunc MaxiSorp, VWR, CA, USA) plate
overnight at 4uC. Afterward the 96-well plate was washed with
PBST (PBS + 0.05% Tween-20) and then blocked with 1% BSA.
The 96 well plate was washed again with PBST and incubated
with lectin (Wheat germ agglutinin, WGA) (Sigma-Aldrich, MO,
USA), conjugated to horseradish peroxidase (HRP; 5 mg/ml)
(Sigma-Aldrich, MO, USA), at 37uC for 1 hr. The substrate,
3,39,5,59-Tetramethylbenzidine (TMB; Sigma-Aldrich, MO,
USA), was added to each well at room temperature followed by
H2SO4 (Sigma-Aldrich, MO, USA) in order to terminate the
reaction. The optical density was measured at 450 nm [37].
Titanium Dioxide Stimulates Mucin Secretion
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After staining the treated cells, image analysis was performed
with an inverted Nikon Eclipse TE2000-U fluorescent microscope.
Each photo was taken at a magnification of 2006 and analyzed
using SimplePCI (Compix Inc., Imaging Systems, Sewickle, PA,
USA). The data shown is a representative of Ca
2+ signals of more
than 200 cells.
8. Statistical Analysis
The data was presented as means6SD. Each experiment was
performed independently at least three times. Statistical signifi-
cance was determined using a Student’s t-test analysis with p




Dynamic laser scattering (DLS) was used to characterize the
TiO2 NPs. The particle size distribution ranged from ,9t o8 0n m
due to minor aggregation or agglomeration while the predominant
size is ,50 nm (Fig. 1A).
TiO2 NPs induce cytosolic Ca
2+ concentration increase
To investigate whether TiO2 NPs could generate an increase in
[Ca
2+]C, ChaGo-K1 cells were loaded with Rhod-2 AM dye and
exposed to 0.05–1 mg/ml of TiO2 NPs. The change in [Ca
2+]C,a s
represented by the fluorescence intensity within ChaGo-K1 cells,
was monitored for 60 seconds. Figure 1B shows that 1 mg/ml of
TiO2 NPs induced an approximate 150% increase, while lower
TiO2 concentrations (,0.1 mg/ml) caused a minor elevation
(,110%) in [Ca
2+]C when compared with untreated cells. The
effect of TiO2 treatment on the [Ca
2+]C of ChaGo-K1 cells
followed a concentration-dependent manner (Fig. 1B).
Extracellular source for Ca
2+ increase
To determine the main source of elevated [Ca
2+]C upon
stimulation, ChaGo-K1 cells were exposed to TiO2 NPs in Ca
2+-
free Hanks’ solution. EGTA (2 mM) was added in Hanks’ solution
to chelate possible traces of Ca
2+. TiO2 (0.05 mg/ml–1 mg/ml)
treatment under Ca
2+-free conditions failed to instigate a
significant increase in [Ca
2+]C (Fig. 2A). Our data suggests that
the extracellular Ca
2+ pool is the primary source of the observed
cytosolic Ca
2+ increase. We then tested whether TiO2 NPs can
induce a Ca
2+ influx via membrane channels. Blocking the
channels with CdCl2 (200 mM) significantly inhibited an increase
in [Ca
2+]C (Fig. 2B). Co-treatment of cells with TiO2 NPs and
nifedipine greatly blocked the NP-induced [Ca
2+]C increase
(Fig. 2C). However, the incomplete blockage of extracellular
Ca
2+ influx via channels postulates additional Ca
2+ leakage
through perturbed cell membranes. To confirm whether TiO2
can instigate membrane disruption, thereby permitting unspecific
extracellular Ca
2+ entry, cytosolic leakage was assessed using the
fluorescent calcein dye. It was found that the dye permeation ratio
increased from approximately 4 to 13% with elevated TiO2
concentrations ranging from 0.1 to 1 mg/ml (Fig. 2D).
Oxidative stress induced Ca
2+ influx
To demonstrate that TiO2-evoked [Ca
2+]C increase can be
associated with oxidative stress, cells were pretreated with an anti-
oxidant, N-acetylcysteine (NAC) [27]. Pre-treatment with NAC
was able to partially attenuate the increase in cytosolic Ca
2+ level
triggered by 1 mg/ml and 0.75 mg/ml TiO2 exposure (Fig. 2E).
These results support the idea that oxidative stress, induced by




The ER as an intracellular source of Ca
2+
In order to determine the involvement of ER Ca
2+ pool, it
was depleted by pre-incubating the cells with thapsigargin.
Pre-treatment with thapsigargin impeded TiO2 NPs from
triggering a sustained increase in the cytosolic Ca
2+ level
(Fig. 3A). We then investigated the role of the CICR mechanism
by blocking RYRs (ryanodine receptors) [20]. Our results
revealed that CICR was largely inhibited by ryanodine (a blocker
for RYR associated with the CICR response) resulting in a
significantly diminished [Ca
2+]C increase induced by NPs
(Fig. 3B).
Figure 1. TiO2 NP characterization and resultant [Ca
2+]C changes after NP treatment. A) DLS assessment of TiO2 NPs in Hanks’ solution
showed a size distribution of ,9 to 80 nm. B) Cells were treated with TiO2 NPs with concentrations of 0.05 mg/ml (yellow), 0.1 mg/ml (Light Blue),
0.25 mg/ml (Purple), 0.5 mg/ml (Green), 0.75 mg/ml (Red), and 1 mg/ml (Blue) in normal Hanks’ solution. Each line represents the average
fluorescence intensity of approximately 200 cells per well.
doi:10.1371/journal.pone.0016198.g001
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2+-dependency of TiO2-induced mucin secretion
Enzyme-linked lectin assay (ELLA) was used to assess the
amount of mucin secreted from ChaGo-K1 cells when stimulated
with TiO2 NPs. When compared to the control, TiO2 NPs
increased mucin secretion by 113%, 125%, 133%, 137% and
150% at 0.05, 0.1, 0.25, 0.5 and 0.75 mg/ml, respectively
(Fig. 4A). Chelating the intracellular Ca
2+ with BAPTA-AM
yielded a significant reduction in mucin secretion (Fig 4B).
Addition of thapsigargin (Fig. 4C) or ryanodine (Fig. 4D) also
resulted in diminished mucin secretion induced by TiO2 NPs. Our
data indicates that TiO2-induced mucin secretion is dependent on
the [Ca
2+]C, attributed to both external and internal Ca
2+ pools
(Fig. 4A–D). Ionomycin (a Ca
2+ ionophore) was used to elicit
mucin secretion as a positive control (Fig. 5).
Figure 2. Measurement of the [Ca
2+]C and calcein dye leakage after TiO2 NP treatment. Cells were treated with TiO2 NPs with
concentrations ranging from 0.05 mg/ml–1 mg/ml, in A) Ca
2+-free Hanks’ solution, B) in the presence of CdCl2 (200 mM), C) nifedipine (10 mM), D)
calcein (50 mM) (n=12, **P,0.005), and E) NAC (250 mM) (colors are as depicted in Figure 1B).
doi:10.1371/journal.pone.0016198.g002
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2+]C after stimulation by TiO2 NPs. Cells were treated with TiO2 NPs with concentrations ranging from 0.1 mg/ml
–1 mg/ml, in the presence of A) thapsigargin (100 nM), and B) ryanodine (100 mM) (colors used are consistent with Figure 1).
doi:10.1371/journal.pone.0016198.g003
Figure 4. Measurement of mucin secretion triggered by TiO2 NPs. Cells were treated with TiO2 NP concentrations ranging from 0.05 mg/ml
–0.75 mg/ml. Figure 4A) shows the relative quantification of mucin secreted after TiO2 stimulation under normal conditions (n$7, **P,0.005), 4B) in
the presence of BAPTA-AM (50 mM) (n$9), 4C) with pre-treatment of thapsigargin (100 nM) (n$8), 4D), and with ryanodine (100 mM) (n$5).
doi:10.1371/journal.pone.0016198.g004
Titanium Dioxide Stimulates Mucin Secretion
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Recently, an increasing number of reports have shown that
airborne particulate pollution found in both the ambient and
working environments, particularly TiO2 NPs, can exacerbate
airway diseases [1,2,3,4,5,6,10,11,38]. Aggravated clinical mani-
festations of COPD, CF and asthma may include intensified
symptoms of mucociliary transport impairment and mucus
hypersecretion [15,39]. The resultant accumulation of thick
obstructive mucus usually occupies airway lumen, thereby limiting
airflow and leading to morbidity [15,39]. Despite documentations
of TiO2-induced cellular nanotoxicity effects, pulmonary inflam-
matory responses and emphysema-like pathology [12], whether
TiO2 NPs can directly trigger mucin secretion has not been
resolved. In this study, we demonstrate that TiO2 NPs can
stimulate mucin secretion from bronchial epithelial ChaGo-K1
cells via a Ca
2+- dependent pathway.
Our study showed that TiO2 NPs can induce mucin secretion
that increases as a function of TiO2 NP concentration (Fig. 4A).
The TiO2 concentration range used in our study is consistent with
previous reports representing the concentration found in ambience
and nanotechnology industries [30,40,41,42]. While NP exposure
has been long associated with increasing mucin synthesis due to
goblet cell hyperplasia [13], our study indicates that TiO2 NPs can
directly trigger mucin secretion in the airway.
IthasbeenwellestablishedthatintracellularCa
2+playsavitalrole
in stimulus-secretion coupling [43]. Previous reports have docu-
mented that an elevated [Ca
2+]C precedes mucin granule exocytosis
[17]. NP exposure has been shown to trigger an intracellular Ca
2+
increase in various cells; therefore, we examined the cellular Ca
2+
signaling pathway involved during TiO2 stimulation [25,28,44]. At
TiO2 concentrations of 0.5, 0.75, and 1 mg/ml, there was a
sustained elevation in [Ca
2+]C. At lower doses (0.05, 0.1 and
0.25 mg/ml), the [Ca
2+]C increased gradually within the 1
st minute
(Fig. 1B). Our data demonstrated that TiO2 NPs induced a
concentration dependent increase in [Ca
2+]C, which is consistent
with results from the mucin secretion measurements (Fig. 4A).
The stimulus-induced intracellular Ca
2+ signal can be evoked by
the entry of Ca
2+ through voltage-gated Ca
2+ channels, or by the
release of Ca
2+ from intracellular Ca
2+ stores [43,45,46]. Previous
researches have suggested that extracellular Ca
2+ influx plays an
important role in the elevated [Ca
2+]C during NP stimulation
[25,27,28,47]. Data from experiments performed in Ca
2+-free
Hanks’ solution confirmed that [Ca
2+]C failed to increase when
treated with TiO2 NPs (Fig. 2A). To characterize the nature of the
Ca
2+ influx induced by TiO2 NPs, we first evaluated the effect of
cadmium chloride (CdCl2), a general Ca
2+ channel blocker
[34,48]. Figure 2B shows that the [Ca
2+]C remained low and
relatively unchanged with CdCl2. Secondly, nifedipine, a widely
used L-type Ca
2+ channel blocker, markedly diminished the
increase in [Ca
2+]C (Fig. 2C). The effect of nifedipine implies that
TiO2 NPs can activate L-type voltage gated Ca
2+ channels,
allowing extracellular Ca
2+ influx into the cytosol. This observa-
tion is consistent with previous reports showing that ultrafine
carbon black and ZnO NP-induced [Ca
2+]C elevation can also be
attenuated by nifedipine [27,28]. In addition, several reports have
suggested that oxidative stress induced by NPs can exert an impact
on the intracellular Ca
2+ signaling pathway and that the activity of
Ca
2+ channels may be altered by ROS [27,28,44]. Results from
Figure 2E showed that NAC significantly reduced the rising
[Ca
2+]C generated by TiO2 NPs. Huang et al, has also
demonstrated that NAC can attenuate the intracellular Ca
2+ level
when challenged with ZnO NPs [27]. Our results support the idea
that NAC and other antioxidants may be effective in reducing NP-
instigated mucin hypersecretion. NPs such as TiO2 can damage
cell membrane integrity by possible lipid peroxidation [27,31],
thereby creating pores on the lipid bilayer [49] that may allow the
transient influx of extracellular Ca
2+. Our data further demon-
strated that co-adminstration of TiO2 NPs and fluorescent calcein
dye lead to intracellular leakage and the permeation efficiency
increased in a TiO2 concentration dependent manner (Fig. 2D).
Calcein has also been previously utilized to evaluate the efficacy of
peptides in causing membrane perturbation [50]. Our result
suggests that the possible membrane perturbation/transient pore
formation induced by TiO2 NPs allows an extracellular Ca
2+
influx and may account for the portion of Ca
2+ that can not be




2+]C of human goblet cells has been shown to
trigger degranulation [17]. We used BAPTA (cytosolic Ca
2+
chelator) to test whether the increase in Ca
2+ induced by TiO2
NPs could stimulate mucin exocytosis. It is evident that BAPTA
significantly inhibited mucin exocytosis (Fig. 4B), indicating that
TiO2 NPs can elicit a [Ca
2+]C increase, thereby leading to mucin
secretion.
Besides the external Ca
2+ source (Hanks’ solution), the ER is
one of the major internal Ca
2+ stores. Figures 3A and 4C revealed
that when the ER Ca
2+ had been depleted by pretreatment with
thapsigargin, the TiO2 NP-induced [Ca
2+]C failed to increase
significantly, and the subsequent mucin secretion was abolished.
Our data indicates that the ER plays a critical role in relaying
TiO2-induced Ca
2+ signaling. CICR is a positive feedback
mechanism where the ER amplifies a small increase in [Ca
2+]C,
(e.g. due to voltage-gated Ca
2+ influx [22]), with the activation of
RYRs that will lead to the release of more Ca
2+ from the ER
[19,20]. Previous studies have shown that through activation of
RYRs with Ca
2+, CICR can generate an overall increase in
[Ca
2+]C [20,21,22]. Our data showed that ryanodine inhibited a
continual rise in [Ca
2+]C when applying TiO2 NPs (Fig. 3B).
Therefore, it is indicative that the TiO2-instigated increase in
[Ca
2+]C was also CICR dependent. The effect of ryanodine was
further demonstrated by the lack of mucin secretion under TiO2
NP stimulation (Fig. 4D).
Figure 5. Mucin secretion in response to ionomycin application
(positive control, n$3). Concentration of ionomycin used was 1 mM.
doi:10.1371/journal.pone.0016198.g005
Titanium Dioxide Stimulates Mucin Secretion
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NPs can activate membrane L-type Ca
2+ channels, induce ROS
production and possibly disrupt the cellular membrane. Influx of
extracellular Ca
2+ into the cytoplasm raises [Ca
2+]C, which in turn
can trigger ryanodine receptors on the ER to release ER resident
Ca
2+ via the CICR mechanism. A sufficient increase in the
cytosolic Ca
2+ level results in subsequent mucin secretion. More
importantly, our results provide a direct link between airborne
particulate matters and the pathogenesis of chronic airway diseases
involving mucus hypersecretion and airway obstruction. In
addition, we demonstrate that once thought inert and harmless
TiO2 NPs can indeed interfere with intracellular Ca
2+ signaling,
possibly leading to pathological states.
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